Stay updated on CF33-hNIS-antiPDL1 in Metastatic TNBC Clinical Trial
Sign up to get notified when there's something new on the CF33-hNIS-antiPDL1 in Metastatic TNBC Clinical Trial page.

Latest updates to the CF33-hNIS-antiPDL1 in Metastatic TNBC Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedAdded revision entry v3.4.2 to the Record History and removed revision v3.4.1.SummaryDifference0.1%

- Check19 days agoChange DetectedA new version entry v3.4.1 was added to the Record History and the previous v3.4.0 version was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check41 days agoChange DetectedThe history now shows the addition of revision v3.3.4 and the removal of revision v3.3.3 from the record history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedA new revision entry, Revision: v3.3.3, was added to the Record History. The HHS Vulnerability Disclosure item and Revision: v3.3.2 were removed.SummaryDifference0.2%

- Check92 days agoChange DetectedRevision entries show v3.3.2 added and v3.2.0 removed; these are minor metadata changes to the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check99 days agoChange DetectedRemoved the notice about potential data delays due to government funding lapses and links to operating-status updates.SummaryDifference0.7%

Stay in the know with updates to CF33-hNIS-antiPDL1 in Metastatic TNBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CF33-hNIS-antiPDL1 in Metastatic TNBC Clinical Trial page.